Thus, in the context of existing colonic tumors, the presence of M. morganii-producing indolimines could contribute to AHR activation in combination with other tryptophan metabolites, such as kynurenine, in the intestinal tumor microenvironment, likely leading to enhanced tumor outgrowth and immune suppression. This evidence concerns the gene AHR and neoplasm.